img

Global Enasidenib Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Enasidenib Market Research Report 2024

Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
According to Mr Accuracy reports new survey, global Enasidenib market is projected to reach US$ 125.9 million in 2029, increasing from US$ 78 million in 2022, with the CAGR of 7.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Enasidenib market research.
Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Enasidenib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bristol Myers Squibb
Segment by Type
50mg
100mg

Segment by Application


Hospital
Pharmacy

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Enasidenib report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Enasidenib Market Overview
1.1 Product Overview and Scope of Enasidenib
1.2 Enasidenib Segment by Type
1.2.1 Global Enasidenib Market Value Comparison by Type (2024-2034)
1.2.2 50mg
1.2.3 100mg
1.3 Enasidenib Segment by Application
1.3.1 Global Enasidenib Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Enasidenib Market Size Estimates and Forecasts
1.4.1 Global Enasidenib Revenue 2018-2029
1.4.2 Global Enasidenib Sales 2018-2029
1.4.3 Global Enasidenib Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Enasidenib Market Competition by Manufacturers
2.1 Global Enasidenib Sales Market Share by Manufacturers (2018-2024)
2.2 Global Enasidenib Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Enasidenib Average Price by Manufacturers (2018-2024)
2.4 Global Enasidenib Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Enasidenib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enasidenib, Product Type & Application
2.7 Enasidenib Market Competitive Situation and Trends
2.7.1 Enasidenib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enasidenib Players Market Share by Revenue
2.7.3 Global Enasidenib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enasidenib Retrospective Market Scenario by Region
3.1 Global Enasidenib Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Enasidenib Global Enasidenib Sales by Region: 2018-2029
3.2.1 Global Enasidenib Sales by Region: 2018-2024
3.2.2 Global Enasidenib Sales by Region: 2024-2029
3.3 Global Enasidenib Global Enasidenib Revenue by Region: 2018-2029
3.3.1 Global Enasidenib Revenue by Region: 2018-2024
3.3.2 Global Enasidenib Revenue by Region: 2024-2029
3.4 North America Enasidenib Market Facts & Figures by Country
3.4.1 North America Enasidenib Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Enasidenib Sales by Country (2018-2029)
3.4.3 North America Enasidenib Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Enasidenib Market Facts & Figures by Country
3.5.1 Europe Enasidenib Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Enasidenib Sales by Country (2018-2029)
3.5.3 Europe Enasidenib Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enasidenib Market Facts & Figures by Country
3.6.1 Asia Pacific Enasidenib Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Enasidenib Sales by Country (2018-2029)
3.6.3 Asia Pacific Enasidenib Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Enasidenib Market Facts & Figures by Country
3.7.1 Latin America Enasidenib Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Enasidenib Sales by Country (2018-2029)
3.7.3 Latin America Enasidenib Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enasidenib Market Facts & Figures by Country
3.8.1 Middle East and Africa Enasidenib Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Enasidenib Sales by Country (2018-2029)
3.8.3 Middle East and Africa Enasidenib Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enasidenib Sales by Type (2018-2029)
4.1.1 Global Enasidenib Sales by Type (2018-2024)
4.1.2 Global Enasidenib Sales by Type (2024-2029)
4.1.3 Global Enasidenib Sales Market Share by Type (2018-2029)
4.2 Global Enasidenib Revenue by Type (2018-2029)
4.2.1 Global Enasidenib Revenue by Type (2018-2024)
4.2.2 Global Enasidenib Revenue by Type (2024-2029)
4.2.3 Global Enasidenib Revenue Market Share by Type (2018-2029)
4.3 Global Enasidenib Price by Type (2018-2029)
5 Segment by Application
5.1 Global Enasidenib Sales by Application (2018-2029)
5.1.1 Global Enasidenib Sales by Application (2018-2024)
5.1.2 Global Enasidenib Sales by Application (2024-2029)
5.1.3 Global Enasidenib Sales Market Share by Application (2018-2029)
5.2 Global Enasidenib Revenue by Application (2018-2029)
5.2.1 Global Enasidenib Revenue by Application (2018-2024)
5.2.2 Global Enasidenib Revenue by Application (2024-2029)
5.2.3 Global Enasidenib Revenue Market Share by Application (2018-2029)
5.3 Global Enasidenib Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Enasidenib Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Bristol Myers Squibb Enasidenib Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enasidenib Industry Chain Analysis
7.2 Enasidenib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enasidenib Production Mode & Process
7.4 Enasidenib Sales and Marketing
7.4.1 Enasidenib Sales Channels
7.4.2 Enasidenib Distributors
7.5 Enasidenib Customers
8 Enasidenib Market Dynamics
8.1 Enasidenib Industry Trends
8.2 Enasidenib Market Drivers
8.3 Enasidenib Market Challenges
8.4 Enasidenib Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Enasidenib Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Enasidenib Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Enasidenib Market Competitive Situation by Manufacturers in 2022
Table 4. Global Enasidenib Sales (Units) of Key Manufacturers (2018-2024)
Table 5. Global Enasidenib Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Enasidenib Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Enasidenib Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Enasidenib Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Enasidenib, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Enasidenib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enasidenib, Product Type & Application
Table 12. Global Key Manufacturers of Enasidenib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enasidenib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enasidenib Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Enasidenib Sales by Region (2018-2024) & (Units)
Table 18. Global Enasidenib Sales Market Share by Region (2018-2024)
Table 19. Global Enasidenib Sales by Region (2024-2029) & (Units)
Table 20. Global Enasidenib Sales Market Share by Region (2024-2029)
Table 21. Global Enasidenib Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Enasidenib Revenue Market Share by Region (2018-2024)
Table 23. Global Enasidenib Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Enasidenib Revenue Market Share by Region (2024-2029)
Table 25. North America Enasidenib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Enasidenib Sales by Country (2018-2024) & (Units)
Table 27. North America Enasidenib Sales by Country (2024-2029) & (Units)
Table 28. North America Enasidenib Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Enasidenib Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Enasidenib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Enasidenib Sales by Country (2018-2024) & (Units)
Table 32. Europe Enasidenib Sales by Country (2024-2029) & (Units)
Table 33. Europe Enasidenib Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Enasidenib Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Enasidenib Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Enasidenib Sales by Region (2018-2024) & (Units)
Table 37. Asia Pacific Enasidenib Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Enasidenib Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Enasidenib Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Enasidenib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Enasidenib Sales by Country (2018-2024) & (Units)
Table 42. Latin America Enasidenib Sales by Country (2024-2029) & (Units)
Table 43. Latin America Enasidenib Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Enasidenib Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Enasidenib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Enasidenib Sales by Country (2018-2024) & (Units)
Table 47. Middle East & Africa Enasidenib Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Enasidenib Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Enasidenib Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Enasidenib Sales (Units) by Type (2018-2024)
Table 51. Global Enasidenib Sales (Units) by Type (2024-2029)
Table 52. Global Enasidenib Sales Market Share by Type (2018-2024)
Table 53. Global Enasidenib Sales Market Share by Type (2024-2029)
Table 54. Global Enasidenib Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Enasidenib Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Enasidenib Revenue Market Share by Type (2018-2024)
Table 57. Global Enasidenib Revenue Market Share by Type (2024-2029)
Table 58. Global Enasidenib Price (USD/Unit) by Type (2018-2024)
Table 59. Global Enasidenib Price (USD/Unit) by Type (2024-2029)
Table 60. Global Enasidenib Sales (Units) by Application (2018-2024)
Table 61. Global Enasidenib Sales (Units) by Application (2024-2029)
Table 62. Global Enasidenib Sales Market Share by Application (2018-2024)
Table 63. Global Enasidenib Sales Market Share by Application (2024-2029)
Table 64. Global Enasidenib Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Enasidenib Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Enasidenib Revenue Market Share by Application (2018-2024)
Table 67. Global Enasidenib Revenue Market Share by Application (2024-2029)
Table 68. Global Enasidenib Price (USD/Unit) by Application (2018-2024)
Table 69. Global Enasidenib Price (USD/Unit) by Application (2024-2029)
Table 70. Bristol Myers Squibb Corporation Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Enasidenib Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Bristol Myers Squibb Enasidenib Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Enasidenib Distributors List
Table 78. Enasidenib Customers List
Table 79. Enasidenib Market Trends
Table 80. Enasidenib Market Drivers
Table 81. Enasidenib Market Challenges
Table 82. Enasidenib Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enasidenib
Figure 2. Global Enasidenib Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Enasidenib Market Share by Type in 2022 & 2029
Figure 4. 50mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Enasidenib Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Enasidenib Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Enasidenib Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Enasidenib Market Size (2018-2029) & (US$ Million)
Figure 12. Global Enasidenib Sales (2018-2029) & (Units)
Figure 13. Global Enasidenib Average Price (USD/Unit) & (2018-2029)
Figure 14. Enasidenib Report Years Considered
Figure 15. Enasidenib Sales Share by Manufacturers in 2022
Figure 16. Global Enasidenib Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Enasidenib Players: Market Share by Revenue in 2022
Figure 18. Enasidenib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Enasidenib Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Enasidenib Sales Market Share by Country (2018-2029)
Figure 21. North America Enasidenib Revenue Market Share by Country (2018-2029)
Figure 22. the United States Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Enasidenib Sales Market Share by Country (2018-2029)
Figure 25. Europe Enasidenib Revenue Market Share by Country (2018-2029)
Figure 26. Germany Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Enasidenib Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Enasidenib Revenue Market Share by Region (2018-2029)
Figure 33. China Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Enasidenib Sales Market Share by Country (2018-2029)
Figure 43. Latin America Enasidenib Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Enasidenib Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Enasidenib Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Enasidenib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Enasidenib by Type (2018-2029)
Figure 53. Global Revenue Market Share of Enasidenib by Type (2018-2029)
Figure 54. Global Enasidenib Price (USD/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Enasidenib by Application (2018-2029)
Figure 56. Global Revenue Market Share of Enasidenib by Application (2018-2029)
Figure 57. Global Enasidenib Price (USD/Unit) by Application (2018-2029)
Figure 58. Enasidenib Value Chain
Figure 59. Enasidenib Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed